{ "company_number": "07446062", "name": "Canopy Life Sciences Ltd", "url": "/company/07446062", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2010-11-22", "dissolved_on": null, "sic_codes": [ { "code": "74909", "description": "Other professional, scientific and technical activities n.e.c.", "section": "M", "section_name": "Professional, scientific and technical activities", "url": "/sic/74909" } ], "registered_address": { "id": 1994128, "url": "/address/1994128", "line1": "70 THE BROADWAY", "line2": "", "post_town": "CHESHAM", "county": "", "country": "ENGLAND", "postcode": "HP5 1EG" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07446062", "previous_names": [ { "name": "Pharmaceutical Econsulting Limited", "ceased_on": "2015-12-23" }, { "name": "Onix Life Sciences Limited", "ceased_on": "2023-09-20" } ], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-09-30", "last_made_up": "2024-12-31", "category": "UNAUDITED ABRIDGED", "filings": [ { "url": "/company/07446062/accounts/2025-12-31", "pdf_url": "/company/07446062/accounts/2025-12-31.pdf", "made_up_date": "2025-12-31", "period_start": "2025-12-31", "period_end": "2025-12-31", "entity_name": "Canopy Life Sciences Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "3347442.00", "debtors": "183095.00", "cash_bank_in_hand": "456950.00", "current_assets": "640045.00", "creditors_due_within_one_year": "221843.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "418202.00", "total_assets_less_current_liabilities": "3765644.00", "net_assets_liabilities": "3765644.00", "called_up_share_capital": "2500.00", "profit_loss_account_reserve": "1073835.00", "shareholder_funds": "2500.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Bulk_Data-2026-08-27.zip" }, { "url": "/company/07446062/accounts/2024-12-31", "pdf_url": "/company/07446062/accounts/2024-12-31.pdf", "made_up_date": "2024-12-31", "period_start": "2024-12-31", "period_end": "2024-12-31", "entity_name": "Canopy Life Sciences Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "4798168.00", "debtors": "164269.00", "cash_bank_in_hand": "131980.00", "current_assets": "296249.00", "creditors_due_within_one_year": "182506.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "113743.00", "total_assets_less_current_liabilities": "4911911.00", "net_assets_liabilities": "4911911.00", "called_up_share_capital": "2500.00", "profit_loss_account_reserve": "2115028.00", "shareholder_funds": "2500.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2025.zip" }, { "url": "/company/07446062/accounts/2023-12-31", "pdf_url": "/company/07446062/accounts/2023-12-31.pdf", "made_up_date": "2023-12-31", "period_start": "2023-12-31", "period_end": "2023-12-31", "entity_name": "Canopy Life Sciences Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "4798168.00", "debtors": "265566.00", "cash_bank_in_hand": "156490.00", "current_assets": "422056.00", "creditors_due_within_one_year": "336563.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "85493.00", "total_assets_less_current_liabilities": "4883661.00", "net_assets_liabilities": "4883661.00", "called_up_share_capital": "2500.00", "profit_loss_account_reserve": "1690522.00", "shareholder_funds": "2500.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2024.zip" }, { "url": "/company/07446062/accounts/2022-09-30", "pdf_url": "/company/07446062/accounts/2022-09-30.pdf", "made_up_date": "2022-09-30", "period_start": "2022-09-30", "period_end": "2022-09-30", "entity_name": "Onix Life Sciences Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "50451.00", "debtors": "214814.00", "cash_bank_in_hand": "1407053.00", "current_assets": "1621867.00", "creditors_due_within_one_year": "175004.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1446863.00", "total_assets_less_current_liabilities": "1497314.00", "net_assets_liabilities": "1497314.00", "called_up_share_capital": "2500.00", "profit_loss_account_reserve": "1494814.00", "shareholder_funds": "2500.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2023.zip" }, { "url": "/company/07446062/accounts/2021-09-30", "pdf_url": "/company/07446062/accounts/2021-09-30.pdf", "made_up_date": "2021-09-30", "period_start": "2021-09-30", "period_end": "2021-09-30", "entity_name": "Onix Life Sciences Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "53163.00", "debtors": "235736.00", "cash_bank_in_hand": "825876.00", "current_assets": "1061612.00", "creditors_due_within_one_year": "120461.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "941151.00", "total_assets_less_current_liabilities": "994314.00", "net_assets_liabilities": "994314.00", "called_up_share_capital": "2500.00", "profit_loss_account_reserve": "991814.00", "shareholder_funds": "2500.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2022.zip" }, { "url": "/company/07446062/accounts/2020-09-30", "pdf_url": "/company/07446062/accounts/2020-09-30.pdf", "made_up_date": "2020-09-30", "period_start": "2020-09-30", "period_end": "2020-09-30", "entity_name": "Onix Life Sciences Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "813796.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "666999.00", "total_assets_less_current_liabilities": "666999.00", "net_assets_liabilities": "666999.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "666999.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2021.zip" }, { "url": "/company/07446062/accounts/2019-09-30", "pdf_url": "/company/07446062/accounts/2019-09-30.pdf", "made_up_date": "2019-09-30", "period_start": "2019-09-30", "period_end": "2019-09-30", "entity_name": "Onix Life Sciences Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "555059.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "479107.00", "total_assets_less_current_liabilities": "479107.00", "net_assets_liabilities": "479107.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "479107.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2020.zip" }, { "url": "/company/07446062/accounts/2018-09-30", "pdf_url": "/company/07446062/accounts/2018-09-30.pdf", "made_up_date": "2018-09-30", "period_start": "2018-09-30", "period_end": "2018-09-30", "entity_name": "Onix Life Sciences Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "545045.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "472605.00", "total_assets_less_current_liabilities": "472605.00", "net_assets_liabilities": "472605.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "472605.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2019.zip" }, { "url": "/company/07446062/accounts/2017-09-30", "pdf_url": "/company/07446062/accounts/2017-09-30.pdf", "made_up_date": "2017-09-30", "period_start": "2017-09-30", "period_end": "2017-09-30", "entity_name": "Onix Life Sciences Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "549001.00", "creditors_due_within_one_year": "98842.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "450159.00", "total_assets_less_current_liabilities": "450159.00", "net_assets_liabilities": "450159.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "450159.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2018.zip" }, { "url": "/company/07446062/accounts/2016-09-30", "pdf_url": "/company/07446062/accounts/2016-09-30.pdf", "made_up_date": "2016-09-30", "period_start": "2016-09-30", "period_end": "2016-09-30", "entity_name": "Onix Life Sciences Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "164785.00", "cash_bank_in_hand": "238717.00", "current_assets": "403502.00", "creditors_due_within_one_year": "132529.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "270973.00", "total_assets_less_current_liabilities": "270973.00", "net_assets_liabilities": "270973.00", "called_up_share_capital": "2000.00", "profit_loss_account_reserve": "268473.00", "shareholder_funds": "270973.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2017.zip" }, { "url": "/company/07446062/accounts/2015-09-30", "pdf_url": "/company/07446062/accounts/2015-09-30.pdf", "made_up_date": "2015-09-30", "period_start": "2015-09-30", "period_end": "2015-09-30", "entity_name": "Pharmaceutical Econsulting Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "73424.00", "cash_bank_in_hand": null, "current_assets": "534434.00", "creditors_due_within_one_year": "275128.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "259306.00", "total_assets_less_current_liabilities": "259306.00", "net_assets_liabilities": "259306.00", "called_up_share_capital": "2500.00", "profit_loss_account_reserve": "256806.00", "shareholder_funds": "259306.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2015.zip" }, { "url": "/company/07446062/accounts/2014-09-30", "pdf_url": "/company/07446062/accounts/2014-09-30.pdf", "made_up_date": "2014-09-30", "period_start": "2014-09-30", "period_end": "2014-09-30", "entity_name": "Pharmaceutical Econsulting Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "192245.00", "cash_bank_in_hand": "135502.00", "current_assets": "327747.00", "creditors_due_within_one_year": "211647.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "116100.00", "total_assets_less_current_liabilities": "116100.00", "net_assets_liabilities": "116100.00", "called_up_share_capital": "2500.00", "profit_loss_account_reserve": "113600.00", "shareholder_funds": "116100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2015.zip" }, { "url": "/company/07446062/accounts/2013-09-30", "pdf_url": "/company/07446062/accounts/2013-09-30.pdf", "made_up_date": "2013-09-30", "period_start": "2013-09-30", "period_end": "2013-09-30", "entity_name": "Pharmaceutical Econsulting Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "55127.00", "cash_bank_in_hand": "123061.00", "current_assets": "178188.00", "creditors_due_within_one_year": "109825.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "68363.00", "total_assets_less_current_liabilities": "68363.00", "net_assets_liabilities": "68363.00", "called_up_share_capital": "500.00", "profit_loss_account_reserve": "67863.00", "shareholder_funds": "68363.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2014.zip" }, { "url": "/company/07446062/accounts/2012-09-30", "pdf_url": "/company/07446062/accounts/2012-09-30.pdf", "made_up_date": "2012-09-30", "period_start": "2012-09-30", "period_end": "2012-09-30", "entity_name": "Pharmaceutical Econsulting Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "77930.00", "cash_bank_in_hand": "116666.00", "current_assets": "194596.00", "creditors_due_within_one_year": "150687.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "43909.00", "total_assets_less_current_liabilities": "43909.00", "net_assets_liabilities": "43909.00", "called_up_share_capital": "500.00", "profit_loss_account_reserve": "43409.00", "shareholder_funds": "43909.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2013.zip" }, { "url": "/company/07446062/accounts/2011-09-30", "pdf_url": "/company/07446062/accounts/2011-09-30.pdf", "made_up_date": "2011-09-30", "period_start": "2011-09-30", "period_end": "2011-09-30", "entity_name": "Pharmaceutical Econsulting Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "34343.00", "cash_bank_in_hand": "81047.00", "current_assets": "115390.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "41099.00", "total_assets_less_current_liabilities": "41099.00", "net_assets_liabilities": "41099.00", "called_up_share_capital": "500.00", "profit_loss_account_reserve": "40599.00", "shareholder_funds": "41099.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2012.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/07446062/filing-history" }, "confirmation_statement": { "next_due": "2026-12-06", "last_made_up": "2025-11-22" }, "officers": [], "psc": [ { "name": "Mrs Jasbir Chohan", "kind": "individual-person-with-significant-control", "person_url": "/person/2208648", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2016-11-22", "ceased_on": "2023-02-28", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Canopy Life Sciences Llc", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": null, "natures_of_control": [ "right-to-appoint-and-remove-directors" ], "notified_on": "2023-02-28", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-29T20:59:03.591456+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }